NCT00961220 2018-05-22O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell LymphomaNational Cancer Institute (NCI)Phase 1/2 Completed17 enrolled 6 charts
NCT00005961 2013-02-11O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic MelanomaNational Cancer Institute (NCI)Phase 2 Completed40 enrolled